Product Information
MONTELUKAST SOD 5 MG TAB CHEW is a generic product labeled by Chartwell RX LLC, priced at $0.0704 per EA under NDC 62135078230. Its NADAC has been published 138 times since Feb 14, 2024.
FDA first approved this application on Aug 3, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Chartwell RX LLCNDC
62135078230
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MONTELUKAST SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA200405FDA Approved
8/3/2012
TE Code
AB
On Market Since
8/3/2012
Pharmacological Classes
Price Statistics
The NADAC for MONTELUKAST SOD 5 MG TAB CHEW has been published 138 times since Feb 14, 2024, and over the history we have for it it has declined 16.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0704 per EA |
|---|---|
| All-time high | $0.0842 (Feb 14, 2024) |
| All-time low | $0.0600 (Nov 20, 2024) |
| 52-week high | $0.0742 |
| 52-week low | $0.0678 |
| Median price | $0.0711 |
| Average price | $0.0716 |
| Largest weekly change | -15.4% (Apr 17, 2024) |
| Weeks tracked | 138 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the MONTELUKAST SODIUM market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
MONTELUKAST SODIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Leukotriene Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MONTELUKAST SOD 5 MG TAB CHEW?
The current National Average Drug Acquisition Cost (NADAC) for MONTELUKAST SOD 5 MG TAB CHEW, manufactured by Chartwell RX LLC, is $0.0704 per EA (NDC 62135078230), effective Sep 30, 2026.
How has the price of MONTELUKAST SOD 5 MG TAB CHEW changed over time?
Over the history we have for it, the NADAC for MONTELUKAST SOD 5 MG TAB CHEW has declined 16.3%. It has been tracked across 138 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for MONTELUKAST SOD 5 MG TAB CHEW?
Since Feb 14, 2024, the NADAC for MONTELUKAST SOD 5 MG TAB CHEW has ranged from a low of $0.0600 (Nov 20, 2024) to a high of $0.0842 (Feb 14, 2024), with a median of $0.0711 per EA.
Are there cheaper alternatives to MONTELUKAST SOD 5 MG TAB CHEW?
No other NADAC-published product currently shares the active ingredient and strength of MONTELUKAST SOD 5 MG TAB CHEW in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MONTELUKAST SOD 5 MG TAB CHEW?
MONTELUKAST SOD 5 MG TAB CHEW (NDC 62135078230) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.